Hyogo College of Medicine Hospital

Hyogo, Nishinomiya 663-8501

2 studies enrolling now · 6 studies all time

What they study most

Colitis, Ulcerative, Hemorrhage, Liver Fibrosis, Mesothelioma, Metabolic Dysfunction Associated Steatohepatitis (MASH), Pyoderma Gangrenosum

Studies at this site

• LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis — Recruiting now
• A Study to Test Whether Spesolimab Helps People With a Skin Condition Called Pyoderma Gangrenosum — Recruiting now
• BI 655130 Long-term Treatment in Patients With moderate-to Severe Ulcerative Colitis — Completed
• BI655130 (SPESOLIMAB) Induction Treatment in Patients With Moderate-to-severe Ulcerative Colitis — Completed
• Nintedanib (BIBF 1120) in Mesothelioma — Stopped early
• Reversal of Dabigatran Anticoagulant Effect With Idarucizumab — Completed